HouseMarketBook

164 Broadway, Gillingham

Semi-detached house · Freehold · ME8 6DR

Sold for, November 2006£158,000No floor area on record

Sold for £158,000 in November 2006.

Indexed with the UK House Price Index for Medway, that sale is worth about £313,800 today. The 100 semi-detached houses counted in ME8 6 over the last 24 months sold for a median of £3,750 per square metre. No energy certificate matches this address, so there is no floor area and no price per square metre; its sold prices are shown in full.

Today's value£313,800
ME8 6 median, semi-detached house£3,750per m²

Sale history

HM Land Registry · 3 sales since 1995
DatePrice paid£ / m²Growth / yrAfter inflationToday's value
Nov 2006£158,000—+11.1%+9.3%£313,800
Jun 1998£65,500—+36%+33.4%£357,400
Sep 1996£38,000———£245,000

Growth is the compound annual rate between one sale and the next, shown when they are at least a year apart; after inflation uses CPIH for the same months. Today's value indexes each sale forward with the UK House Price Index for Medway to September 2026.

Recent sales in ME8 6

Newest first
AddressDatePriceSize£ / m²
222 Lower Twydall LaneSep 2026£295,00076 m²£3,880
15 Hawthorne AvenueSep 2026£370,00092 m²£4,020
19 Lyminge CloseSep 2026£303,00075 m²£4,040
28 Staplehurst RoadSep 2026£275,00074 m²£3,720
20 Lyminge CloseSep 2026£300,00075 m²£4,000
3 Charing RoadSep 2026£265,00068 m²£3,900
288 BroadwayAug 2026£280,00070 m²£4,000
77 Featherby RoadAug 2026£295,00097 m²£3,040
67 Thornham RoadAug 2026£275,00069 m²£3,990
2 ElmfieldAug 2026£481,000151 m²£3,190
Everything in ME8 6

About this page

What did 164 Broadway sell for? 164 Broadway last sold for £158,000 in November 2006. HM Land Registry records 3 sales since 1996. Price per square metre is the price paid divided by that area; today's value indexes the latest sale forward with the UK House Price Index. None of these figures is a valuation.

Sales to September 2026 · HM Land Registry price paid data · MHCLG energy certificates · UK House Price Index to September 2026 · An index-based comparison of sold prices, not a valuation.